Latest News
All Times Eastern
- DocuSign shares rise after earnings, and other movers
- Barron's DocuSign, Apple, Smartsheet, Guidewire Software, RH, and More Stock Market Movers
- U.S. stock futures lean higher after difficult week on Wall Street
- Barron's Banks Are Stuck in a Rut. A Buyout Wave Could Be Building.
- Barron's High-Quality Dividend Stocks Are on Sale. Now Is the Time to Buy.
- Barron's Why Walt Disney Could Cave First in Its Cable Standoff With Charter
- Barron's 5 Federal Deficit Myths, Explained
- Barron's Walgreens Is Looking for a New CEO. Why That Could Make the Stock a Winner.
- Barron's Active Funds Rocked August. Passive Is Grabbing the Year.
- Barron's It’s Not Just BlackRock. Exchanges Like Nasdaq Are Pushing into Crypto, Too.
to be replaced
Centene Corp.
CNCUS
$
0.66
0.99%
After Hours
$
67.10
After Hours Volume:
256.31K
| Close | Chg | Chg % |
|---|---|---|
| $66.44 | 3.12 | 4.93% |
Volume: 6.93M
65 Day Avg: 3.35M
63.50
Day Range
67.13
60.83
52 Week Range
93.58
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
CNC Overview
Key Data
- Open $63.70
- Day Range 63.50 - 67.13
- 52 Week Range 60.83 - 93.58
- Market Cap $34.29B
- Shares Outstanding 541.48M
- Public Float 537.74M
- Beta 0.90
- Rev. per Employee $1.991M
- P/E Ratio 13.69
- EPS $4.85
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 6.14M 08/15/23
- % of Float Shorted 1.14%
- Average Volume 3.35M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 21
Full Ratings
Recent News
Centene sets guidance for 2023 ahead of investor day
Centene Corp. set guidance for 2023 on Friday and said it expects revenue for the year to range from $137.4 billion to $139.4 billion. The current FactSet consensus is for revenue of $144.3 billion. The healthcare company...
Centene board adds $2 bln to share buyback authorization
Centene (CNC): A Hidden Gem in the Healthcare Sector? An In-Depth Analysis of Its Market Value
Centene (CNC): A Hidden Gem in the Healthcare Sector? An In-Depth Analysis of Its Market Value
on GuruFocus.com
A Deep Dive Into Centene and AMN Healthcare Through the Eyes of Peter Lynch
A Deep Dive Into Centene and AMN Healthcare Through the Eyes of Peter Lynch
on GuruFocus.com
A Deep Dive into Centene and AMN Healthcare Through the Lens of the Peter Lynch Growth Screen
A Deep Dive into Centene and AMN Healthcare Through the Lens of the Peter Lynch Growth Screen
on GuruFocus.com
Stocks That Hit 52-Week Lows On Friday
on Benzinga.com
Centene (CNC)'s Hidden Bargain: An In-Depth Look at the 25% Margin of Safety Based on its Valuation
Centene (CNC)'s Hidden Bargain: An In-Depth Look at the 25% Margin of Safety Based on its Valuation
on GuruFocus.com
Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023
on Benzinga.com
8 Analysts Have This to Say About Centene
on Benzinga.com
Bernstein Reaffirms Their Buy Rating on Centene (CNC)
on TipRanks.com
(CNC) - Analyzing Centene's Short Interest
on Benzinga.com
Centene Corp.
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| HCA Healthcare Inc. | $74.68B | |
| IQVIA Holdings Inc. | $40.07B | |
| Laboratory Corp. of America Holdings | $18.13B | |
| Icon PLC | $21.03B | |
| Teladoc Health Inc. | $3.79B | |
| Quest Diagnostics Inc. | $14.27B | |
| DaVita Inc. | $9.03B | |
| Universal Health Services Inc. Cl B | $7.92B |